Carmen Escuriola-Ettingshausen, MD

Physician
Haemophilia Centre Rhine-Main, Mörfelden-Walldorf, Germany

Dr Carmen Escuriola Ettingshausen is the Director of the Haemophilia Centre Rhein Main - HZRM, Frankfurt-Mörfelden, Germany.

Her research interests are Haemorrhagic disorders, particularly in treatment of haemophiliacs and haemophiliacs with inhibitors, where also contributed to numerous publications. Moreover, she is member of the German, Swiss and Austrian Society For Thrombosis and Haemostasis Research (GTH), International Society for Thrombosis and Haemostasis (ISTH), the International Prophylaxis Study Group (IPSG) and other working groups focused on the treatment of haemophilia.

Presentation(s):

• PB0181 - Bleeding according to FVIII activity in 641 children with non-severe haemophilia - data from the PedNet study group

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0193 - Dose optimization for prophylaxis using a pharmacokinetic model for factor IX products in severe hemophilia B

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0219 - Thrombin generation measurement in hemophilia A patients with inhibitors receiving emicizumab prophylaxis

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 30.2 - Efficacy of emicizumab prophylaxis in patients with severe hemophilia A in Germany: Real-life-data documented by eDiary smart medication

  Monday, July 11, 2022
  11:00 AM – 11:15 AM

• OC 70.5 - Bleeding in non-severe haemophilia A and B – data from the PedNet study group.

  Wednesday, July 13, 2022
  11:15 AM – 11:30 AM